GlassScriptPhysician profile
Nancy P Schenk
NPI 1467413971
$3,331.10
in general payments reported to CMS, 2019-2025
38 companies · $734 in 2025
The $734 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $308 · 2021: $679 · 2022: $397 · 2023: $579 · 2024: $477 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.22 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $552.03 | 2021-2025 | Ubrelvy, Viberzi, Linzess |
| Astellas Pharma US INC | $464.72 | 2019-2025 | Veozah |
| Amgen INC. | $366.88 | 2019-2025 | Evenity |
| Novo Nordisk INC | $321.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $289.79 | 2021-2025 | |
| Grifols USA, LLC | $104.18 | 2022-2023 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $101.52 | 2021-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Glaxosmithkline, LLC. | $89.62 | 2020-2025 | Shingrix, Trelegy Ellipta |
| Amarin Pharma, INC. | $88.76 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $84.74 | 2022-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $78.77 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $75.33 | 2021-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $60.72 | 2021 | |
| Medtronic, INC. | $56.61 | 2022-2025 | Symplicity G3 |
| Otsuka America Pharmaceutical, INC. | $50.18 | 2023-2025 | Rexulti |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Schenk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.